HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions

Breast Cancer Research and Treatment

Volumn 140, Issue 3, 2013, Pages 505-517

  Fanale, Daniele ^a   Bazan, Viviana ^a   Corsini, Lidia Rita ^a   Caruso, Stefano ^a   Insalaco, Lavinia ^a   Castiglia, Marta ^a   Cicero, Giuseppe ^a   Bronte, Giuseppe ^a   Russo, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

AURKA; Breast cancer; Cell cycle; HIF 1 ; Hypoxia

Indexed keywords

AURORA A KINASE; HYPOXIA INDUCIBLE FACTOR 1; AURKA PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; BREAST CANCER CELL LINE; CELL HYPOXIA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

AURORA KINASE A; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROMOTER REGIONS, GENETIC;

EID: 84898703864     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2649-0     Document Type: Article

References (53)

1. Lech R, Przemyslaw O (2011) Epidemiological models for breast cancer risk estimation. Ginekol Pol 82(6):451-454
2. Alvarez RH, Valero V, Hortobagyi GN (2010) Emerging targeted therapies for breast cancer. J Clin Oncol 28(20):3366-3379. doi:10.1200/JCO.2009.25.4011
3. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869-10874. doi:10.1073/pnas.191367098
4. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO, Botstein D (2002) Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 13(6):1977-2000. doi:10.1091/mbc.02-02-0030
5. Liu J, Campen A, Huang S, Peng SB, Ye X, Palakal M, Dunker AK, Xia Y, Li S (2008) Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data. BMC Med Genomics 1:39. doi:10.1186/1755-8794-1-39
6. Golias CH, Charalabopoulos A, Charalabopoulos K (2004) Cell proliferation and cell cycle control: a mini review. Int J Clin Pract 58(12):1134-1141
7. Williams GH, Stoeber K (2012) The cell cycle and cancer. J Pathol 226(2):352-364. doi:10.1002/path.3022
8. Fu J, Bian M, Jiang Q, Zhang C (2007) Roles of aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 5(1):1-10. doi:10.1158/1541-7786.MCR-06-0208
9. Vader G, Lens SM (2008) The aurora kinase family in cell division and cancer. Biochim Biophys Acta 1786(1):60-72. doi:10.1016/j.bbcan.2008.07.003
10. Barr AR, Gergely F (2007) Aurora-A: the maker and breaker of spindle poles. J Cell Sci 120(Pt 17):2987-2996. doi:10.1242/jcs.013136
11. El-Rifai W, Frierson HF Jr, Harper JC, Powell SM, Knuutila S (2001) Expression profiling of gastric adenocarcinoma using cDNA array. Int J Cancer 92(6):832-838. doi:10.1002/ijc.1264
12. Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okano Y (1999) Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 59(9):2041-2044
13. Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC, Katz RL, Brinkley W, Czerniak B (2002) Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94(17):1320-1329
14. Klein A, Flugel D, Kietzmann T (2008) Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1. Mol Biol Cell 19(9):3667-3675. doi:10.1091/mbc.E08-01-0042
15. Wu CC, Yang TY, Yu CT, Phan L, Ivan C, Sood AK, Hsu SL, Lee MH (2012) p53 negatively regulates aurora A via both transcriptional and posttranslational regulation. Cell Cycle 11(18):3433-3442. doi:10.4161/cc.21732
16. Lehman NL, O’Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, Schultz LR, Williams CJ, Mikkelsen T, Brown SL, Ecsedy JA, Poisson LM (2012) Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas. Cell Cycle 11(3):489-502. doi:10.4161/cc.11.3.18996
17. Agnese V, Bazan V, Fiorentino FP, Fanale D, Badalamenti G, Colucci G, Adamo V, Santini D, Russo A (2007) The role of aurora-A inhibitors in cancer therapy. Ann Oncol 18(Suppl 6):47-52. doi:10.1093/annonc/mdm224
18. Rademakers SE, Span PN, Kaanders JH, Sweep FC, van der Kogel AJ, Bussink J (2008) Molecular aspects of tumour hypoxia. Mol Oncol 2(1):41-53. doi:10.1016/j.molonc.2008.03.006
19. Brown JM (2002) Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 1(5):453-458
20. Semenza G (2002) Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64(5-6):993-998
21. Knowles HJ, Harris AL (2001) Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis. Breast Cancer Res 3(5):318-322
22. Wenger A, Kowalewski N, Stahl A, Mehlhorn AT, Schmal H, Stark GB, Finkenzeller G (2005) Development and characterization of a spheroidal coculture model of endothelial cells and fibroblasts for improving angiogenesis in tissue engineering. Cells Tissues Organs 181(2):80-88. doi:10.1159/000091097
23. Schwab LP, Peacock DL, Majumdar D, Ingels JF, Jensen LC, Smith KD, Cushing RC, Seagroves TN (2012) Hypoxia-inducible factor 1a promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Breast Cancer Res 14(1):R6. doi:10.1186/bcr3087
24. Pugh CW, Gleadle J, Maxwell PH (2001) Hypoxia and oxidative stress in breast cancer. Hypoxia signalling pathways. Breast Cancer Res 3(5):313-317
25. Kimbro KS, Simons JW (2006) Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 13(3):739-749. doi:10.1677/erc.1.00728
26. Vaupel P (2004) The role of hypoxia-induced factors in tumor progression. Oncologist 9(suppl 5):10-17. doi:10.1634/theoncologist.9-90005-10
27. Peurala E, Koivunen P, Bloigu R, Haapasaari KM, Jukkola-Vuorinen A (2012) Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients. Breast Cancer Res Treat 133(1):179-188. doi:10.1007/s10549-011-1750-5
28. Kaelin WG Jr (2003) The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J Am Soc Nephrol 14(11):2703-2711
29. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL (2005) Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105(2):659-669. doi:10.1182/blood-2004-07-2958
30. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC (2003) Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23(24):9361-9374
31. Giatromanolaki A, Harris AL (2001) Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res 21(6):4317-4324
32. Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, Iwase H (2008) Hypoxia-inducible factor 1a is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat 110(3):465-475. doi:10.1007/s10549-007-9742-1
33. Chen KF, Lai YY, Sun HS, Tsai SJ (2005) Transcriptional repression of human cad gene by hypoxia inducible factor-1a. Nucl Acids Res 33(16):5190-5198. doi:10.1093/nar/gki839
34. Feige E, Yokoyama S, Levy C, Khaled M, Igras V, Lin RJ, Lee S, Widlund HR, Granter SR, Kung AL, Fisher DE (2011) Hypoxiainduced transcriptional repression of the melanoma-associated oncogene MITF. Proc Natl Acad Sci USA 108(43):E924-E933. doi:10.1073/pnas.1106351108
35. Ryu K, Park C, Lee Y (2011) Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells. Biochem Biophys Res Commun 407(4):831-836. doi:10.1016/j.bbrc.2011.03.119
36. Federico M, Symonds CE, Bagella L, Rizzolio F, Fanale D, Russo A, Giordano A (2010) R-Roscovitine (seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders nonhomologous end-joining (NHEJ) DNA repair. Mol Cancer 9:208. doi:10.1186/1476-4598-9-208
37. Gautier L, Cope L, Bolstad BM, Irizarry RA (2004) Affy— analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20(3):307-315. doi:10.1093/bioinformatics/btg405
38. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2):249-264. doi:10.1093/biostatistics/4.2.249
39. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3, Article 3. doi:10.2202/1544-6115.1027
40. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125(1-2):279-284
41. Wettenhall JM, Simpson KM, Satterley K, Smyth GK (2006) affylmGUI: a graphical user interface for linear modeling of single channel microarray data. Bioinformatics 22(7):897-899. doi:10.1093/bioinformatics/btl025
42. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucl Acids Res 28(1):27-30
43. DeSantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics. CA Cancer J Clin 61(6):409-418. doi:10.3322/caac.20134
44. van der Groep P, van Diest PJ, Smolders YH, Ausems MG, van der Luijt RB, Menko FH, Bart J, de Vries EG, van der Wall E (2013) HIF-1alpha overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers. PLoS ONE 8(2):e56055. doi:10.1371/journal.pone.0056055
45. Favaro E, Lord S, Harris AL, Buffa FM (2011) Gene expression and hypoxia in breast cancer. Genome Med 3(8):55. doi:10.1186/gm271
46. Kunz M, Ibrahim SM (2003) Molecular responses to hypoxia in tumor cells. Mol Cancer 2:23
47. Lens SM, Voest EE, Medema RH (2010) Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 10(12):825-841. doi:10.1038/nrc2964
48. Kitajima S, Kudo Y, Ogawa I, Tatsuka M, Kawai H, Pagano M, Takata T (2007) Constitutive phosphorylation of aurora-A on ser51 induces its stabilization and consequent overexpression in cancer. PLoS ONE 2(9):e944. doi:10.1371/journal.pone.0000944
49. Katayama H, Brinkley WR, Sen S (2003) The aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 22(4):451-464
50. Wang LH, Xiang J, Yan M, Zhang Y, Zhao Y, Yue CF, Xu J, Zheng FM, Chen JN, Kang Z, Chen TS, Xing D, Liu Q (2010) The mitotic kinase aurora-A induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway. Cancer Res 70(22):9118-9128. doi:10.1158/0008-5472. CAN-10-1246
51. Yang H, He L, Kruk P, Nicosia SV, Cheng JQ (2006) Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer 119(10):2304-2312. doi:10.1002/ijc.22154
52. Xu J, Li H, Wang B, Xu Y, Yang J, Zhang X, Harten SK, Shukla D, Maxwell PH, Pei D, Esteban MA (2010) VHL inactivation induces HEF1 and aurora kinase A. J Am Soc Nephrol 21(12):2041-2046. doi:10.1681/ASN.2010040345
53. Lee HH, Zhu Y, Govindasamy KM, Gopalan G (2008) Downregulation of aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells. Endocr Relat Cancer 15(3):765-775. doi:10.1677/ERC-07-0213